Magnetic Resonance Imaging Based Clinical Research in Alzheimer's Disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2012-09-18

• Fields of study

  Medicine

• Identifiers
  DOI 10.3233/JAD-2011-111292PMID 22233763
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain oxidative stress: detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy.

  2012cited by this paper
• In vivo proton magnetic resonance spectroscopic signal processing for the absolute quantitation of brain metabolites.

  2012cited by this paper
• A new experimental approach and signal processing scheme for the detection and quantitation of ³¹P brain neurochemicals from in vivo MRS studies using dual tuned (¹H/³¹P) head coil.

  2011cited by this paper
• The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• Excess significance bias in the literature on brain volume abnormalities.

  2011cited by this paper
• Detection of amyloid plaques targeted by USPIO-Aβ1-42 in Alzheimer's disease transgenic mice using magnetic resonance microimaging

  2011cited by this paper
• Magnetic resonance spectroscopy in the prediction of early conversion from amnestic mild cognitive impairment to dementia: a prospective cohort study

  2011cited by this paper
• The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• An MRI substudy of a donepezil clinical trial in mild cognitive impairment.

  2011cited by this paper
• Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

  2011cited by this paper
• [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].

  2010cited by this paper
• ASL Perfusion MRI Predicts Cognitive Decline and Conversion From MCI to Dementia

  2010cited by this paper
• CEREBRAL AMYLOID ANGIOPATHY AND ALZHEIMER'S DISEASE.

  2010cited by this paper
• Automatic Prediction of Conversion from Mild Cognitive Impairment to Probable Alzheimer's Disease using Structural Magnetic Resonance Imaging.

  2010cited by this paper
• Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease.

  2010cited by this paper
• Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment

  2010cited by this paper
• Memantine versus donepezil in mild to moderate Alzheimer’s disease: a randomized trial with magnetic resonance spectroscopy

  2010cited by this paper
• Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease.

  2010cited by this paper
• Comparing predictors of conversion and decline in mild cognitive impairment

  2010cited by this paper
• Magnetic resonance elastography: A review

  2010cited by this paper
• Risk of dementia in MCI

  2009cited by this paper
• MRI and CSF biomarkers in normal, MCI, and AD subjects

  2009cited by this paper
• Alzheimer disease: quantitative structural neuroimaging for detection and prediction of clinical and structural changes in mild cognitive impairment.

  2009cited by this paper
• Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease

  2009cited by this paper
• Amyloid Imaging in Aging and Dementia: Testing the Amyloid Hypothesis In Vivo

  2009cited by this paper
• A meta-analysis of hippocampal atrophy rates in Alzheimer's disease.

  2009cited by this paper
• Mild cognitive impairment: ten years later.

  2009cited by this paper
• A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes

  2009cited by this paper
• Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

  2009cited by this paper
• MRI and CSF biomarkers in normal, MCI, and AD subjects

  2009cited by this paper
• In Vivo Visualization of Senile‐Plaque‐Like Pathology in Alzheimer's Disease Patients by MR Microscopy on a 7T System

  2008cited by this paper
• Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.

  2008cited by this paper
• In vivo brain viscoelastic properties measured by magnetic resonance elastography

  2008cited by this paper
• 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry

  2008cited by this paper
• Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements.

  2008cited by this paper
• Magnetic Resonance Spectroscopy (MRS) and Its Application in Alzheimer's Disease

  2007cited by this paper
• Headache and cerebral venous air embolism

  2007cited by this paper
• Diffusion Tensor Imaging of Normal-Appearing White Matter in Mild Cognitive Impairment and Early Alzheimer Disease: Preliminary Evidence of Axonal Degeneration in the Temporal Lobe

  2007cited by this paper
• Hippocampal and entorhinal atrophy in mild cognitive impairment

  2007cited by this paper
• Automatic calculation of hippocampal atrophy rates using a hippocampal template and the boundary shift integral.

  2007cited by this paper
• Cholinesterase Inhibitors in Mild Cognitive Impairment: A Systematic Review of Randomised Trials

  2007cited by this paper
• Quantitative MR imaging in Alzheimer disease.

  2006cited by this paper
• Conversion of MCI to dementia: Role of proton magnetic resonance spectroscopy.

  2006cited by this paper
• Interpretation of clinical functional neuroimaging studies

  2006cited by this paper
• Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study.

  2006cited by this paper
• MRS shows abnormalities before symptoms in familial Alzheimer disease

  2006cited by this paper
• Mild cognitive impairment

  2006cited by this paper
• Brain volume loss in MCI predicts dementia

  2006cited by this paper
• The effect of drugs for Alzheimer disease assessed by means of neuroradiological techniques.

  2006cited by this paper
• Donepezil for mild cognitive impairment.

  2006cited by this paper
• Changes in Metabolite Ratios after Treatment with Rivastigmine in Alzheimer’s Disease

  2006cited by this paper
• Conversion from mild cognitive impairment to probable Alzheimer's disease predicted by brain magnetic resonance spectroscopy.

  2005cited by this paper
• Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience.

  2005cited by this paper
• Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?

  2005cited by this paper
• MRI predictors of risk of incident Alzheimer disease

  2005cited by this paper
• DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment

  2005cited by this paper
• Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI

  2005cited by this paper
• Magnetic resonance spectroscopy.

  2005cited by this paper
• Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer's disease.

  2004cited by this paper
• Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical "disconnection" in aging and Alzheimer's disease.

  2004cited by this paper
• Imaging cerebral atrophy: normal ageing to Alzheimer's disease.

  2004cited by this paper
• In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent

  2004cited by this paper
• MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD.

  2004cited by this paper
• Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment

  2004cited by this paper
• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Clinical MR neuroimaging : diffusion, perfusion, and spectroscopy

  2004cited by this paper
• Medial temporal lobe function and structure in mild cognitive impairment

  2004cited by this paper
• Biomarkers of Alzheimer's disease and mild cognitive impairment: are we there yet?

  2003cited by this paper
• Randomized, placebo-controlled trial of the effects of donepezil on neuronal markers and hippocampal volumes in Alzheimer's disease.

  2003cited by this paper
• Neuroimaging and early diagnosis of Alzheimer disease: a look to the future.

  2003cited by this paper
• Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD

  2003cited by this paper
• MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD

  2003cited by this paper
• The expanding role of imaging in prion disease.

  2002cited by this paper
• Clinical brain proton magnetic resonance spectroscopy for management of Alzheimer's and sub-cortical ischemic vascular dementia in older people.

  2002cited by this paper
• PROTON MAGNETIC RESONANCE

  2002cited by this paper
• Effects of long-term Donepezil therapy on rCBF of Alzheimer's patients.

  2002cited by this paper
• Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment

  2002cited by this paper
• Brain proton magnetic resonance spectroscopy in Alzheimer disease: changes after treatment with xanomeline.

  2002cited by this paper
• Comparative Diagnostic Utility of Different MR Modalities in Mild Cognitive Impairment and Alzheimer’s Disease

  2002cited by this paper
• 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease

  2002cited by this paper
• A Comprehensive Review of Proton Magnetic Resonance Spectroscopy Studies in Dementia and Parkinson’s Disease

  2002cited by this paper
• Imaging the progression of Alzheimer pathology through the brain

  2002cited by this paper
• Brain perfusion follow-up in Alzheimer's patients during treatment with acetylcholinesterase inhibitors.

  2002cited by this paper
• MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease.

  2001cited by this paper
• Mild cognitive impairment and Alzheimer disease: regional diffusivity of water.

  2001cited by this paper
• Magnetic resonance spectroscopy in AD

  2001cited by this paper
• Is an effective immune intervention for Alzheimer's disease in prospect?

  2001cited by this paper
• Current concepts in mild cognitive impairment.

  2001cited by this paper
• Apolipoprotein E ε4 and the pattern of regional brain atrophy in Alzheimer’s disease

  2001cited by this paper
• Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.

  2001cited by this paper
• Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

  2000cited by this paper
• Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

  2000cited by this paper
• Donepezil therapy in clinical practice: a randomized crossover study.

  2000cited by this paper
• Activate your online subscription

  2000cited by this paper
• Diffusion-weighted imaging in the evaluation of intracranial lesions.

  2000cited by this paper
• Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

  1999cited by this paper
• Elastic model-based segmentation of 3-D neuroradiological data sets

  1999cited by this paper
• Diffusion-Weighted Magnetic Resonance Imaging in Alzheimer’s Disease

  1999cited by this paper
• Neuroanatomic substrates of semantic memory impairment in Alzheimer's disease: Patterns of functional MRI activation

  1999cited by this paper
• Hippocampal system and declarative (relational) memory: Summarizing the data from functional neuroimaging studies

  1999cited by this paper

• Alzheimer’s detection using discrete wavelet transform based image fusion and vision information transformer

  2026cites this paper
• Multi-Modal Fusion and Longitudinal Analysis for Alzheimer’s Disease Classification Using Deep Learning

  2025cites this paper
• Enhancing Alzheimer's Disease Diagnosis via Open Set Domain Adaptation-Based Representation Learning on the Hypersphere

  2024cites this paper
• Distinct profiles of functional connectivity density aberrance in Alzheimer's disease and mild cognitive impairment

  2022cites this paper
• Radiomics-Based Artificial Intelligence Differentiation of Neurodegenerative Diseases with Reference to the Volumetry

  2022cites this paper
• AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer’s Disease: A Retrospective Clinical and Biological Validation

  2021cites this paper
• Brain neurometabolites differences in individuals with subjective cognitive decline plus: a quantitative single- and multi-voxel proton magnetic resonance spectroscopy study.

  2021cites this paper
• Abnormalities of Cortical Sources of Resting State Alpha Electroencephalographic Rhythms are Related to Education Attainment in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment.

  2020cites this paper
• Neuroimaging and analytical methods for studying the pathways from mild cognitive impairment to Alzheimer’s disease: protocol for a rapid systematic review

  2020cites this paper
• Biomarkers of Alzheimer's Disease

  2019cites this paper
• Élastographie par résonance magnétique multifréquence in vitro et ex vivo pour la caractérisation d'agrégats fibrillaires cérébraux. (In vitro and ex vivo multi-frequency magnetic resonance elastography for the characterization of cerebral fibrillar agregates)

  2019cites this paper
• Investigation of metabolism in posterior cingulate cortex in patients with Alzheimer ’ s disease using magnetic resonance spectroscopy

  2016cites this paper
• The superior fault tolerance of artificial neural network training with a fault/noise injection-based genetic algorithm

  2016cites this paper
• Abnormal Resting-State Functional Connectivity Strength in Mild Cognitive Impairment and Its Conversion to Alzheimer's Disease

  2015cites this paper
• T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease

  2015cites this paper
• New perspectives in the search for reliable biomarkers in alzheimer disease

  2015cites this paper
• Multimodality Imaging Approaches in Alzheimer's disease. Part II: 1H MR spectroscopy, FDG PET and Amyloid PET

  2015cites this paper
• Clinical Magnetic Resonance Neuroimaging in Mild Cognitive Impairment and Alzheimer Disease

  2015cites this paper
• Independent Component Analysis-Based Identification of Covariance Patterns of Microstructural White Matter Damage in Alzheimer’s Disease

  2015cites this paper
• Combination of MRI Hippocampal Volumetry and Arterial Spin Labeling MR Perfusion at 3-Tesla Improves the Efficacy in Discriminating Alzheimer's Disease from Cognitively Normal Elderly Adults

  2014cites this paper
• Advances in High-Field Magnetic Resonance Spectroscopy in Alzheimer’s Disease

  2014cites this paper
• An MRI study of age-related changes in the dimensions related temporal lobe.

  2014cites this paper
• Role of emerging neuroimaging modalities in patients with cognitive impairment: a review from the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012

  2013cites this paper
• Structural Interactions within the Default Mode Network Identified by Bayesian Network Analysis in Alzheimer’s Disease

  2013cites this paper
• Neurochemical correlates of cognitive dysfunction in patients with leukoaraiosis: a proton magnetic resonance spectroscopy study

  2012cites this paper
• The contribution of magnetic resonance spectroscopy as biomarker in Alzheimer's disease

  2012cites this paper